These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22431082)

  • 21. Mobility assessment of patients with facioscapulohumeral dystrophy.
    Iosa M; Mazzà C; Frusciante R; Zok M; Aprile I; Ricci E; Cappozzo A
    Clin Biomech (Bristol, Avon); 2007 Dec; 22(10):1074-82. PubMed ID: 17850940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computer-based assessment for facioscapulohumeral dystrophy diagnosis.
    Chambers O; Milenković J; Pražnikar A; Tasič JF
    Comput Methods Programs Biomed; 2015 Jun; 120(1):37-48. PubMed ID: 25910520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between muscle inflammation and fat replacement assessed by MRI in facioscapulohumeral muscular dystrophy.
    Dahlqvist JR; Andersen G; Khawajazada T; Vissing C; Thomsen C; Vissing J
    J Neurol; 2019 May; 266(5):1127-1135. PubMed ID: 30778707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular combing reveals allelic combinations in facioscapulohumeral dystrophy.
    Nguyen K; Walrafen P; Bernard R; Attarian S; Chaix C; Vovan C; Renard E; Dufrane N; Pouget J; Vannier A; Bensimon A; Lévy N
    Ann Neurol; 2011 Oct; 70(4):627-33. PubMed ID: 22028222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid and accurate diagnosis of facioscapulohumeral muscular dystrophy.
    Goto K; Nishino I; Hayashi YK
    Neuromuscul Disord; 2006 Apr; 16(4):256-61. PubMed ID: 16545566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe paraspinal muscle involvement in facioscapulohumeral muscular dystrophy.
    Dahlqvist JR; Vissing CR; Thomsen C; Vissing J
    Neurology; 2014 Sep; 83(13):1178-83. PubMed ID: 25142899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic challenges in facioscapulohumeral muscular dystrophy.
    Sacconi S; Salviati L; Bourget I; Figarella D; Péréon Y; Lemmers R; van der Maarel S; Desnuelle C
    Neurology; 2006 Oct; 67(8):1464-6. PubMed ID: 17060574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Facioscapulohumeral dystrophy.
    Kissel JT
    Semin Neurol; 1999; 19(1):35-43. PubMed ID: 10711987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Typical facioscapulohumeral dystrophy phenotype in patients without FSHD 4q35 deletion.
    Krasnianski M; Neudecker S; Eger K; Jakubiczka S; Zierz S
    J Neurol; 2003 Sep; 250(9):1084-7. PubMed ID: 14504970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MRI change metrics of facioscapulohumeral muscular dystrophy: Stir and T1.
    Ferguson MR; Poliachik SL; Budech CB; Gove NE; Carter GT; Wang LH; Miller DG; Shaw DWW; Friedman SD
    Muscle Nerve; 2018 Jun; 57(6):905-912. PubMed ID: 29236297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe phenotype in infantile facioscapulohumeral muscular dystrophy.
    Klinge L; Eagle M; Haggerty ID; Roberts CE; Straub V; Bushby KM
    Neuromuscul Disord; 2006 Oct; 16(9-10):553-8. PubMed ID: 16934468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early-onset facioscapulohumeral muscular dystrophy type 1 with some atypical features.
    Dorobek M; van der Maarel SM; Lemmers RJ; Ryniewicz B; Kabzińska D; Frants RR; Gawel M; Walecki J; Hausmanowa-Petrusewicz I
    J Child Neurol; 2015 Apr; 30(5):580-7. PubMed ID: 24717985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative muscle ultrasound versus quantitative magnetic resonance imaging in facioscapulohumeral dystrophy.
    Janssen BH; Pillen S; Voet NB; Heerschap A; van Engelen BG; van Alfen N
    Muscle Nerve; 2014 Dec; 50(6):968-75. PubMed ID: 24659533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative MRI reveals decelerated fatty infiltration in muscles of active FSHD patients.
    Janssen B; Voet N; Geurts A; van Engelen B; Heerschap A
    Neurology; 2016 May; 86(18):1700-7. PubMed ID: 27037227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation.
    Winokur ST; Chen YW; Masny PS; Martin JH; Ehmsen JT; Tapscott SJ; van der Maarel SM; Hayashi Y; Flanigan KM
    Hum Mol Genet; 2003 Nov; 12(22):2895-907. PubMed ID: 14519683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrent somatic mosaicism for D4Z4 contractions in a family with facioscapulohumeral muscular dystrophy.
    Buzhov BT; Lemmers RJ; Tournev I; van der Wielen MJ; Ishpekova B; Petkov R; Petrova J; Frants RR; Padberg GW; van der Maarel SM
    Neuromuscul Disord; 2005 Jul; 15(7):471-5. PubMed ID: 15935668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patients.
    Rijkers T; Deidda G; van Koningsbruggen S; van Geel M; Lemmers RJ; van Deutekom JC; Figlewicz D; Hewitt JE; Padberg GW; Frants RR; van der Maarel SM
    J Med Genet; 2004 Nov; 41(11):826-36. PubMed ID: 15520407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rimmed vacuoles in facioscapulohumeral muscular dystrophy: a unique ultrastructural feature.
    Neudecker S; Krasnianski M; Bahn E; Zierz S
    Acta Neuropathol; 2004 Sep; 108(3):257-9. PubMed ID: 15221332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular diagnosis of facioscapulohumeral muscular dystrophy.
    Upadhyaya M; Cooper DN
    Expert Rev Mol Diagn; 2002 Mar; 2(2):160-71. PubMed ID: 11962336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decomposition-based quantitative electromyography in the evaluation of muscular dystrophy severity.
    Derry KL; Venance SL; Doherty TJ
    Muscle Nerve; 2012 Apr; 45(4):507-13. PubMed ID: 22431083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.